A5085758098- Mental Health and Patient Involvement
- Patient-Provider Communication in Healthcare
- Psychiatric care and mental health services
- Family Caregiving in Mental Illness
- Schizophrenia research and treatment
- Cannabis and Cannabinoid Research
- Healthcare Decision-Making and Restraints
- Patient Satisfaction in Healthcare
- Child and Adolescent Health
- Palliative Care and End-of-Life Issues
- Gastrointestinal motility and disorders
- Global Cancer Incidence and Screening
- Parkinson's Disease Mechanisms and Treatments
- Glycogen Storage Diseases and Myoclonus
- Cerebral Palsy and Movement Disorders
- Medicinal Plant Extracts Effects
- Health Policy Implementation Science
- Religion, Spirituality, and Psychology
- Optimism, Hope, and Well-being
- Family and Patient Care in Intensive Care Units
- Child Nutrition and Feeding Issues
- Color perception and design
- Clinical practice guidelines implementation
- Occupational Therapy Practice and Research
- Transcranial Magnetic Stimulation Studies
Psychiatry Research Trust
2020
King's College London
2014-2019
The University of Adelaide
2019
Breast Cancer Care
1998
Background There is consensus about the importance of ‘recovery’ in mental health services, but link between recovery orientation teams and personal individuals has been underresearched. Aims To investigate differences team leader, clinician service user perspectives community adult England. Method In six English National Health Service (NHS) trusts, randomly chosen were surveyed. A random sample ten patients, one leader a convenience five clinicians surveyed from each team. All respondents...
Cancer pain (CP) is a prevalent condition with limited pharmacotherapeutic options. Cannabis-based medicinal products (CBMPs) have shown analgesic effects, but their efficacy in CP remains contentious. This study aims to evaluate the change patient-reported outcome measures (PROMs) and adverse events (AEs) patients treated CBMPs. A case series was conducted using prospectively collected clinical data from UK Medical Cannabis Registry. Primary outcomes were changes Brief Pain Inventory (BPI),...
Objective The study aims to evaluate the clinical outcomes in patients with hypermobility spectrum disorder (HSD) and hypermobile Ehlers–Danlos syndrome (hEDS) chronic pain following treatment cannabis‐based medicinal products (CBMPs). Methods This was a case series conducted UK Medical Cannabis Registry. primary were changes validated patient‐reported outcome measures at 1, 3, 6, 12, 18 months compared baseline: Short‐Form McGill Pain Questionnaire 2 (SF‐MPQ‐2), visual analog scale score...
Cannabis-based medicinal products (CBMPs) are a potential treatment for post-traumatic stress disorder (PTSD), but their long-term efficacy and safety need further investigation. This study assessed the changes in health-related quality of life (HRQoL) adverse events PTSD patients prescribed CBMPs. observational cohort included enrolled on UK Medical Cannabis Registry 18 months or longer. Changes PTSD-specific symptoms (IES-R), anxiety (GAD-7), sleep (SQS), general HRQoL (EQ-5D-5 L) were at...
ABSTRACT Background A third of epilepsy patients fail to enter seizure remission despite optimal therapeutic management. Cannabis‐based medicinal products (CBMPs) have shown promise as a potential therapy. However, paucity high‐quality literature regarding CBMPs’ efficacy and safety profile means further investigation is needed. The study aimed examine changes in epilepsy‐specific general health‐related quality life (HRQoL) patient‐reported outcome measures (PROMs) individuals with...
To investigate staff and trainer perspectives on the barriers facilitators to implementing a complex intervention help support recovery of service users with primary diagnosis psychosis in community mental health teams.Process evaluation nested within cluster randomised controlled trial (RCT).28 interviews care staff, 3 trainers, 4 focus groups teams 28 written reports.14 community-based two UK sites (one urban, one semi-rural) who received intervention.The factors influencing implementation...
Objective Decision‐making between mental health clinicians and patients is under‐researched. We tested whether are more satisfied with a decision made (i) using their preferred decision‐making style (ii) clinician the same preference. Method As part of CEDAR Study ( ISRCTN 75841675), convenience sample 445 severe illness from six European countries were assessed for desired clinical (rated by paired clinicians), decision‐specific experienced satisfaction. Results Patients who involvement in...
Smoothly curved objects elicit feelings of pleasantness, and tend to be preferred over angular objects. Furthermore, individual differences (i.e., art expertise, openness experience, holistic thinking), the complexity stimuli are known moderate effect. We extended study two theoretically-relevant groups. Study 1 compared liking for curvature in individuals with autism a matched neurotypical control group (for age, gender IQ). Because preference depends on both sensory (visuospatial)...
The aim of this study was to develop and evaluate a brief quantitative five-language measure involvement satisfaction in clinical decision-making (CDIS) – with versions for patients (CDIS-P) staff (CDIS-S) use mental health services. An English CDIS developed by reviewing existing measures, focus groups, semistructured interviews piloting. Translations into Danish, German, Hungarian Italian followed the International Society Pharmacoeconomics Outcomes Research (ISPOR) Task Force principles...
Clinical decision-making is the vehicle of health care provision, and level involvement predicts implementation satisfaction. The aim this study was to investigate impact experience on recovery. Data derived from an observational cohort "Clinical decision making outcome in routine for people with severe mental illness" (CEDAR). Adults (aged 18–60) meeting standardised criteria illness were recruited caseloads outpatient community services six European countries. After consenting, they...
Generalized anxiety disorder (GAD) is a common mental health condition. The endocannabinoid system has become focus for new therapies, increasing interest in cannabis-based medicinal products (CBMPs). This study uses data from the UK Medical Cannabis Registry (UKMCR) to investigate real-world outcomes and safety of different CBMP formulations GAD patients.
Background Treatments for inflammatory bowel disease (IBD) remain limited, and cannabis-based medicinal products (CBMPs) provide promise in addressing inflammation pain. However, long-term data on CBMP efficacy IBD is scarce. This study examines health-related quality of life (HRQoL) changes patients treated with CBMPs.
The helping alliance (HA) refers to the collaborative bond between patient and therapist, including shared goals tasks. People with severe mental illness have a complex mixture of clinical social needs. Using mixed-effects regression, this study examined in 588 people whether an increase HA is associated fewer unmet needs over time, change precedes It was found that reduction slower patients higher (B = 0.04, p < 0.0001) only for patient-rated measures. Improvement both staff-rated time...
Background: The REFOCUS intervention was a whole team, complex intervention, designed to increase the recovery support offered by community based, mental health staff. consisted of two components: <em>Recovery promoting relationships</em>, which focused on how staff work with service users, and working practices</em>, what activities tasks users could do together.